Amedeo Smart

Free Medical Literature Service


 

Amedeo

Bacterial Infections and Mycoses

  Free Subscription

Articles published in
PLoS Med
    May 2024
  1. JAMES LP, Klaassen F, Sweeney S, Furin J, et al
    Impact and cost-effectiveness of the 6-month BPaLM regimen for rifampicin-resistant tuberculosis in Moldova: A mathematical modeling analysis.
    PLoS Med. 2024;21:e1004401.
    >> Share

    April 2024
  2. CHEN L, Xing Y, Zhang Y, Xie J, et al
    Long-term variations of urban-Rural disparities in infectious disease burden of over 8.44 million children, adolescents, and youth in China from 2013 to 2021: An observational study.
    PLoS Med. 2024;21:e1004374.
    >> Share

    March 2024
  3. EMANI S, Alves K, Alves LC, da Silva DA, et al
    Quantifying gaps in the tuberculosis care cascade in Brazil: A mathematical model study using national program data.
    PLoS Med. 2024;21:e1004361.
    >> Share

    February 2024
  4. SEMITALA FC, Kadota JL, Musinguzi A, Welishe F, et al
    Comparison of 3 optimized delivery strategies for completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV in Uganda: A single-center randomized trial.
    PLoS Med. 2024;21:e1004356.
    >> Share

    November 2023
  5. BRENNHOFER SA, Platts-Mills JA, Lewnard JA, Liu J, et al
    Burden of diarrhea and antibiotic use among children in low-resource settings preventable by Shigella vaccination: A simulation study.
    PLoS Med. 2023;20:e1004271.
    >> Share

    October 2023
  6. NARAYAN A, Salindri AD, Keshavjee S, Muyoyeta M, et al
    Prioritizing persons deprived of liberty in global guidelines for tuberculosis preventive treatment.
    PLoS Med. 2023;20:e1004288.
    >> Share

    September 2023
  7. MAFIRAKUREVA N, Mukherjee S, de Souza M, Kelly-Cirino C, et al
    Cost-effectiveness analysis of interventions to improve diagnosis and preventive therapy for paediatric tuberculosis in 9 sub-Saharan African countries: A modelling study.
    PLoS Med. 2023;20:e1004285.
    >> Share

  8. WIENS KE, Xu H, Zou K, Mwaba J, et al
    Estimating the proportion of clinically suspected cholera cases that are true Vibrio cholerae infections: A systematic review and meta-analysis.
    PLoS Med. 2023;20:e1004286.
    >> Share

    July 2023
  9. PORTNOY A, Arcand JL, Clark RA, Weerasuriya CK, et al
    The potential impact of novel tuberculosis vaccine introduction on economic growth in low- and middle-income countries: A modeling study.
    PLoS Med. 2023;20:e1004252.
    >> Share

  10. MEHTA SD, Zulaika G, Agingu W, Nyothach E, et al
    Analysis of bacterial vaginosis, the vaginal microbiome, and sexually transmitted infections following the provision of menstrual cups in Kenyan schools: Results of a nested study within a cluster randomized controlled trial.
    PLoS Med. 2023;20:e1004258.
    >> Share

    June 2023
  11. DORVIL N, Rivera VR, Riviere C, Berman R, et al
    Same-day testing with initiation of antiretroviral therapy or tuberculosis treatment versus standard care for persons presenting with tuberculosis symptoms at HIV diagnosis: A randomized open-label trial from Haiti.
    PLoS Med. 2023;20:e1004246.
    >> Share

  12. HU Y, Yang Y, Feng Y, Fang Q, et al
    Prevalence and clonal diversity of carbapenem-resistant Klebsiella pneumoniae causing neonatal infections: A systematic review of 128 articles across 30 countries.
    PLoS Med. 2023;20:e1004233.
    >> Share

    May 2023
  13. MARTINSON NA, Nonyane BAS, Genade LP, Berhanu RH, et al
    Evaluating systematic targeted universal testing for tuberculosis in primary care clinics of South Africa: A cluster-randomized trial (The TUTT Trial).
    PLoS Med. 2023;20:e1004237.
    >> Share

  14. BALIASHVILI D, Blumberg HM, Gandhi NR, Averhoff F, et al
    Hepatitis C care cascade among patients with and without tuberculosis: Nationwide observational cohort study in the country of Georgia, 2015-2020.
    PLoS Med. 2023;20:e1004121.
    >> Share

    April 2023
  15. PAIXAO ES, Ferreira AJ, Dos Santos IO, Rodrigues LC, et al
    Mortality in children under 5 years of age with congenital syphilis in Brazil: A nationwide cohort study.
    PLoS Med. 2023;20:e1004209.
    >> Share

    March 2023
  16. PROCTER SR, Goncalves BP, Paul P, Chandna J, et al
    Maternal immunisation against Group B Streptococcus: A global analysis of health impact and cost-effectiveness.
    PLoS Med. 2023;20:e1004068.
    >> Share

  17. MEMIRIE ST, Tolla MT, Rumpler E, Sato R, et al
    Out-of-pocket expenditures and financial risks associated with treatment of vaccine-preventable diseases in Ethiopia: A cross-sectional costing analysis.
    PLoS Med. 2023;20:e1004198.
    >> Share

    January 2023
  18. MARLEY G, Zou X, Nie J, Cheng W, et al
    Improving cascade outcomes for active TB: A global systematic review and meta-analysis of TB interventions.
    PLoS Med. 2023;20:e1004091.
    >> Share

  19. PORTNOY A, Clark RA, Quaife M, Weerasuriya CK, et al
    The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study.
    PLoS Med. 2023;20:e1004155.
    >> Share

  20. WAHEDI K, Zenner D, Flores S, Bozorgmehr K, et al
    Mandatory, voluntary, repetitive, or one-off post-migration follow-up for tuberculosis prevention and control: A systematic review.
    PLoS Med. 2023;20:e1004030.
    >> Share

    July 2022
  21. BROTHERS TD, Lewer D, Jones N, Colledge-Frisby S, et al
    Opioid agonist treatment and risk of death or rehospitalization following injection drug use-associated bacterial and fungal infections: A cohort study in New South Wales, Australia.
    PLoS Med. 2022;19:e1004049.
    >> Share

    June 2022
  22. NSENGIYUMVA NP, Campbell JR, Oxlade O, Vesga JF, et al
    Scaling up target regimens for tuberculosis preventive treatment in Brazil and South Africa: An analysis of costs and cost-effectiveness.
    PLoS Med. 2022;19:e1004032.
    >> Share

    May 2022

  23. Call for Papers: PLOS Medicine Special Issue on Bacterial Antimicrobial Resistance-Surveillance and Prevention.
    PLoS Med. 2022;19:e1004014.
    >> Share

  24. NYAMWAYA DK, Otiende M, Mwango L, Kariuki SM, et al
    Incidence of chikungunya virus infections among Kenyan children with neurological disease, 2014-2018: A cohort study.
    PLoS Med. 2022;19:e1003994.
    >> Share

  25. QIAN G, Toizumi M, Clifford S, Le LT, et al
    Association of pneumococcal carriage in infants with the risk of carriage among their contacts in Nha Trang, Vietnam: A nested cross-sectional survey.
    PLoS Med. 2022;19:e1004016.
    >> Share

    March 2022
  26. FOSTER N, Nguyen HV, Nguyen NV, Nguyen HB, et al
    Social determinants of the changing tuberculosis prevalence in Viet Nam: Analysis of population-level cross-sectional studies.
    PLoS Med. 2022;19:e1003935.
    >> Share

    February 2022
  27. YANG C, Sobkowiak B, Naidu V, Codreanu A, et al
    Phylogeography and transmission of M. tuberculosis in Moldova: A prospective genomic analysis.
    PLoS Med. 2022;19:e1003933.
    >> Share

    January 2022
  28. FOO C, Shrestha P, Wang L, Du Q, et al
    Integrating tuberculosis and noncommunicable diseases care in low- and middle-income countries (LMICs): A systematic review.
    PLoS Med. 2022;19:e1003899.
    >> Share

  29. HOCKING JS, Wood A, Temple-Smith M, Braat S, et al
    The impact of removing financial incentives and/or audit and feedback on chlamydia testing in general practice: A cluster randomised controlled trial (ACCEPt-able).
    PLoS Med. 2022;19:e1003858.
    >> Share

    December 2021
  30. SEMITALA FC, Kadota JL, Musinguzi A, Nabunje J, et al
    Completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV: Interim analysis of a hybrid type 3 effectiveness-implementation randomized trial.
    PLoS Med. 2021;18:e1003875.
    >> Share

    November 2021
  31. HARDY M, Samuela J, Kama M, Tuicakau M, et al
    Community control strategies for scabies: A cluster randomised noninferiority trial.
    PLoS Med. 2021;18:e1003849.
    >> Share

    September 2021
  32. WEN SCH, Ezure Y, Rolley L, Spurling G, et al
    Gram-negative neonatal sepsis in low- and lower-middle-income countries and WHO empirical antibiotic recommendations: A systematic review and meta-analysis.
    PLoS Med. 2021;18:e1003787.
    >> Share

  33. HUYNH BT, Kermorvant-Duchemin E, Chheang R, Randrianirina F, et al
    Severe bacterial neonatal infections in Madagascar, Senegal, and Cambodia: A multicentric community-based cohort study.
    PLoS Med. 2021;18:e1003681.
    >> Share

    August 2021
  34. CHAN J, Gidding HF, Blyth CC, Fathima P, et al
    Levels of pneumococcal conjugate vaccine coverage and indirect protection against invasive pneumococcal disease and pneumonia hospitalisations in Australia: An observational study.
    PLoS Med. 2021;18:e1003733.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016